THY1 and hepatocellular carcinoma: Given this background, it was logical to investigate the expression of CD90 in hepatocarcinoma cell lines and at the level of primary tumor specimens: enriched populations of CSC-CD90+ cells isolated from HCC lines possess tumorigenic activity when transplanted into immunodeficient mice; the large majority of these CD90+ cells coexpress CD44 [146].